UBS Group’s QIAGEN NV QGENF Stock Holding History

UBS Group’s Portfolio QGENF Stock Details QGENF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-62,415	Closed	-$1.75M	–	8503
2016 Q4	$1.75M	Buy	+62,415	New	+$1.75M	﹤0.01%	3036
2016 Q3	–	Sell	-46,705	Closed	-$1.02M	–	8459
2016 Q2	$1.02M	Buy	+46,705	New	+$1.02M	﹤0.01%	3364
2015 Q2	–	Sell	-67,430	Closed	-$1.7M	–	9379
2015 Q1	$1.7M	Buy	+67,430	New	+$1.7M	﹤0.01%	3087

Other funds holding QGENF

BJCM

Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

GAM

Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return

Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return

UBS Group's QGENF Position: Q1 2017 in Review

UBS Group sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 302,759 shares — an estimated $8.48M sold.

UBS Group first reported a position in QGENF in Q4 2014 and held it in 9 quarters. The position peaked at $8.48M in Q4 2016. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

UBS Group reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
UBS Group sold 302,759 QIAGEN NV shares in Q1 2017, an estimated $8.48M.
UBS Group first reported a position in QIAGEN NV in Q4 2014 and held it in 9 quarters.
UBS Group's QIAGEN NV position peaked at $8.48M in Q4 2016.
6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on UBS Group's 13F filing for Q1 2017, filed 12 May 2017.